These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. In reply: Acquired drug-resistance because of pharmacokinetic variability in a young child with tuberculosis. Garcia-Prats AJ; Donald PR; Schaaf HS Pediatr Infect Dis J; 2014 Nov; 33(11):1205-6. PubMed ID: 25361415 [No Abstract] [Full Text] [Related]
25. Need for Revision of Guidelines for Management of DR-TB in Children. Kumari M; Shah I Indian Pediatr; 2017 Feb; 54(2):164-165. PubMed ID: 28285302 [No Abstract] [Full Text] [Related]
26. Management of Multidrug-Resistant Tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2018 Jun; 39(3):310-324. PubMed ID: 30071546 [TBL] [Abstract][Full Text] [Related]
27. [The analysis of clinical data about the treatment of linezolid against tuberculosis]. Nie WJ; Chu NH Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):601-3. PubMed ID: 24252739 [No Abstract] [Full Text] [Related]
28. M tuberculosis drug resistance in AIDS. Durrheim DN; Levin J; Weyer K Lancet; 1997 Jan; 349(9044):61; author reply 61-2. PubMed ID: 8988144 [No Abstract] [Full Text] [Related]
32. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis. Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491 [TBL] [Abstract][Full Text] [Related]
33. Emerging epidemic of drug resistant tuberculosis in vulnerable populations of developing countries. Hashmi HJ; Javed H; Jamil N Afr Health Sci; 2017 Jun; 17(2):599-602. PubMed ID: 29062361 [No Abstract] [Full Text] [Related]